SYNGAP1 and Anxiety: Interestingly, pharmacological treatment with a GSK3-β inhibitor of the Syngap1 mouse model during the critical period of P10-16 does rescue social, cognitive, and anxiety-related behavior, and partially motor behavior (Verma et al., 2021).